Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Tucker

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
Blood|January 18, 2007
Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primatesAndrás Gruber, Ulla M Marzec, Leslie Bush, et al.
Plos One|April 6, 2016
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceCharles E Bane, Ivan Ivanov, Anton Matafonov, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.
Cellular and Molecular Bioengineering|May 20, 2020
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human PrimateMichael Wallisch, Sven R Olson, Jeffrey Crosby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primatesJeffrey R Crosby, Ulla Marzec, Alexey S Revenko, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesMichael Wallisch, Christina U Lorentz, Hari H S Lakshmanan, et al.
Metabolic Brain Disease|June 21, 2023
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in miceTia C L Kohs, Meghan E Fallon, Ethan C Oseas, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 6, 2023
Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane OxygenationAndrew D Meyer, Catherine R Thorpe, Tamara Fraker, et al.
Cellular and Molecular Bioengineering|April 19, 2021
Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related ThrombosisT C L Kohs, C U Lorentz, J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2022
Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXIHari Hara Sudhan Lakshmanan, Aldrich Estonilo, Stéphanie E Reitsma, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
Blood|January 18, 2007
Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primatesAndrás Gruber, Ulla M Marzec, Leslie Bush, et al.
Plos One|April 6, 2016
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceCharles E Bane, Ivan Ivanov, Anton Matafonov, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.
Cellular and Molecular Bioengineering|May 20, 2020
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human PrimateMichael Wallisch, Sven R Olson, Jeffrey Crosby, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primatesJeffrey R Crosby, Ulla Marzec, Alexey S Revenko, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesMichael Wallisch, Christina U Lorentz, Hari H S Lakshmanan, et al.
Metabolic Brain Disease|June 21, 2023
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in miceTia C L Kohs, Meghan E Fallon, Ethan C Oseas, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 6, 2023
Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane OxygenationAndrew D Meyer, Catherine R Thorpe, Tamara Fraker, et al.
Cellular and Molecular Bioengineering|April 19, 2021
Development of Coagulation Factor XII Antibodies for Inhibiting Vascular Device-Related ThrombosisT C L Kohs, C U Lorentz, J Johnson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 30, 2022
Revised model of the tissue factor pathway of thrombin generation: Role of the feedback activation of FXIHari Hara Sudhan Lakshmanan, Aldrich Estonilo, Stéphanie E Reitsma, et al.
Pageof 14